Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)Stephanie N. Gregory, Sunil Gupta, Jonathan M. Hernandez et al.|Annals of Surgical Oncology|2022Cited by 22
A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial)Martha E. Teke, Kim A. Reiss, Areeba Saif et al.|Annals of Surgical Oncology|2022Cited by 6
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic GrowthSurajit Sinha, Geneti Gaga, Areeba Saif et al.|Cancer Discovery|2025Cited by 2